DE69900698T2 - In 6-S und/oder 8-S durch 3-Methylthiopropanoylrest substituierte 6,8-Dimethylmercaptooctansäure-Derivate und pharmaceutische Zubereitungen zur Behandlung von Krebstumoren - Google Patents

In 6-S und/oder 8-S durch 3-Methylthiopropanoylrest substituierte 6,8-Dimethylmercaptooctansäure-Derivate und pharmaceutische Zubereitungen zur Behandlung von Krebstumoren

Info

Publication number
DE69900698T2
DE69900698T2 DE69900698T DE69900698T DE69900698T2 DE 69900698 T2 DE69900698 T2 DE 69900698T2 DE 69900698 T DE69900698 T DE 69900698T DE 69900698 T DE69900698 T DE 69900698T DE 69900698 T2 DE69900698 T2 DE 69900698T2
Authority
DE
Germany
Prior art keywords
substituted
methylthiopropanoyl
acid derivatives
dimethylmercaptooctanoic
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69900698T
Other languages
English (en)
Other versions
DE69900698D1 (de
Inventor
Gerard Anthony Quash
Jacques Gore
Guy Fournet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of DE69900698D1 publication Critical patent/DE69900698D1/de
Publication of DE69900698T2 publication Critical patent/DE69900698T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69900698T 1998-04-01 1999-04-01 In 6-S und/oder 8-S durch 3-Methylthiopropanoylrest substituierte 6,8-Dimethylmercaptooctansäure-Derivate und pharmaceutische Zubereitungen zur Behandlung von Krebstumoren Expired - Fee Related DE69900698T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804041A FR2777001B1 (fr) 1998-04-01 1998-04-01 Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses

Publications (2)

Publication Number Publication Date
DE69900698D1 DE69900698D1 (de) 2002-02-21
DE69900698T2 true DE69900698T2 (de) 2002-08-08

Family

ID=9524740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69900698T Expired - Fee Related DE69900698T2 (de) 1998-04-01 1999-04-01 In 6-S und/oder 8-S durch 3-Methylthiopropanoylrest substituierte 6,8-Dimethylmercaptooctansäure-Derivate und pharmaceutische Zubereitungen zur Behandlung von Krebstumoren

Country Status (11)

Country Link
US (1) US6117902A (de)
EP (1) EP0947503B1 (de)
JP (1) JP3459884B2 (de)
AT (1) ATE209184T1 (de)
AU (1) AU747867C (de)
CA (1) CA2264985C (de)
DE (1) DE69900698T2 (de)
DK (1) DK0947503T3 (de)
ES (1) ES2167989T3 (de)
FR (1) FR2777001B1 (de)
PT (1) PT947503E (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020385A1 (fr) * 1998-10-02 2000-04-13 Sankyo Company, Limited Derives de dithiol
EP1486495B1 (de) * 1998-10-26 2009-12-09 The Research Foundation of State University of New York Salze von Liponsaürederivaten und deren Verwendung bei der Behandlung von Krankheiten
FR2809727B1 (fr) * 2000-05-31 2002-07-26 Galderma Res & Dev Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US7078402B2 (en) * 2000-05-31 2006-07-18 Centre National De La Recherche Scientifique (Cnrs) Aminothiol ester compounds, pharmaceutical and cosmetics compositions containing same and uses thereof
US6916892B2 (en) * 2001-12-03 2005-07-12 Fina Technology, Inc. Method for transitioning between Ziegler-Natta and metallocene catalysts in a bulk loop reactor for the production of polypropylene
CN101765370B (zh) * 2007-04-18 2014-06-25 基石制药公司 硫辛酸衍生物
US8263653B2 (en) 2007-04-18 2012-09-11 Cornerstone Pharmaceuticals, Inc. Pharmaceutical formulations containing lipoic acid derivatives
CA2684479C (en) * 2007-04-18 2017-11-14 Cornerstone Pharmaceuticals, Inc. Amine salts of lipoic acid derivative and use thereof in the treatment of cancer
KR20110025168A (ko) * 2008-04-04 2011-03-09 로버트 쇼어 약학적 조성물
ES2819175T3 (es) 2014-06-19 2021-04-15 Rafael Pharmaceuticals Inc Compuestos farmacéuticos
CA2965898C (en) 2014-06-19 2021-07-06 Robert Shorr Fatty acid analogs
JP7062592B2 (ja) * 2015-10-15 2022-05-06 アドヴァンスト・バイオデザイン アミノチオールエステル化合物またはその薬学的に許容される塩および対象の癌細胞におけるｈ２ｏ２濃度を増大し得る化合物の組み合わせ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728790B1 (fr) * 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial

Also Published As

Publication number Publication date
DK0947503T3 (da) 2002-05-13
FR2777001B1 (fr) 2000-06-09
FR2777001A1 (fr) 1999-10-08
JP2000001471A (ja) 2000-01-07
ATE209184T1 (de) 2001-12-15
ES2167989T3 (es) 2002-05-16
US6117902A (en) 2000-09-12
AU2253699A (en) 1999-10-14
CA2264985C (fr) 2003-12-09
EP0947503A1 (de) 1999-10-06
AU747867C (en) 2003-01-09
JP3459884B2 (ja) 2003-10-27
PT947503E (pt) 2002-05-31
EP0947503B1 (de) 2001-11-21
AU747867B2 (en) 2002-05-23
CA2264985A1 (fr) 1999-10-01
DE69900698D1 (de) 2002-02-21

Similar Documents

Publication Publication Date Title
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
EA200001146A1 (ru) Производные изотиазола, применимые в качестве противораковых агентов
DE69900698T2 (de) In 6-S und/oder 8-S durch 3-Methylthiopropanoylrest substituierte 6,8-Dimethylmercaptooctansäure-Derivate und pharmaceutische Zubereitungen zur Behandlung von Krebstumoren
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
NO20014925D0 (no) Farmasöytiske forbindelser
DE69229442T2 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
DE3575554D1 (de) Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen.
DE69933885D1 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
GR3034023T3 (en) Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them.
PT732332E (pt) Benzotienilpiperazinas substituidas sua utilizacao como medicamentos e processos para a sua preparacao
DE3787844T2 (de) Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
ATE120447T1 (de) Polyamin-derivate als antineoplastische mittel.
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
DK305184A (da) Hexahydropyrrolo(2,1-a)isoquinolin-derivater
DK0551844T3 (da) Svovlholdige galdesyrederivater
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE96144T1 (de) 2-aminoacetamid derivate.
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ATE41774T1 (de) (+)-cyanidan-3-ol derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung.
DE69904940D1 (de) 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee